Why Philanthropy is Now an Executive Imperative for Healthcare

Created By: Niall Keane
February 26, 2026

The U.S. healthcare sector is navigating one of the most complex operating environments in decades. Demand for care continues to rise, while costs, workforce pressures, and policy uncertainty strain already thin margins. For many health systems, particularly nonprofit providers, the question is no longer how to grow, but how to remain financially resilient while delivering on mission.

The Current Landscape

Over the past year, healthcare financing has been marked by volatility. Public funding streams have proven increasingly unpredictable, insurance costs continue to climb, and many organizations are facing constrained operating flexibility. At the same time, health systems are being asked to do more: expand access, address social determinants of health, invest in clinical innovation, and respond to worsening population health indicators.

Most nonprofit health systems operate with margins of approximately 4–7%, even among large academic medical centers. In this environment, rising labor expenses, supply chain pressures, and reductions or uncertainty in government-sponsored programs limit the ability to reinvest in infrastructure, workforce, and new models of care. The cumulative effect is not abstract; it directly impacts patient experience, access, and outcomes.

Healthcare’s Philanthropic Opportunity

Against this backdrop, philanthropy is undergoing a quiet but significant transformation. Once viewed as supplemental support, philanthropic capital is increasingly functioning as a stabilizing force within healthcare organizations. It enables systems to invest where traditional revenue cannot—supporting innovation, sustaining mission-driven programs, and strengthening long-term financial resilience.

Year-over-year, health philanthropy has grown by leaps and bounds. In fact, health philanthropy represents 10% of total giving in the United States, according to Giving USA. Across the sector, we’ve seen more megagifts and major gifts driving lifesaving clinical research and programming and increasing participation in “DIY’ and peer-to-peer fundraising. 

At academic medical centers, transformational philanthropy is becoming increasingly common. In recent years, Albert Einstein College of Medicine and Johns Hopkins School of Medicine each received $1 billion to support physician education. Memorial Sloan Kettering Cancer Center and Columbia University Vagelos College of Physicians and Surgeons secured $400 million gifts to expand research capacity through major facility investments. Sutter Health received $110 million to broaden access to care across Northern California, while Mass General leveraged a $100 million gift to expand its oncology program. Collectively, these investments illustrate how philanthropy is no longer supplemental but a strategic lever shaping the future of healthcare delivery, education, and research.

Philanthropy as a Stabilizer

The stabilizing role of philanthropy is perhaps most visible as a catalyst for innovation in care delivery. As breakthrough therapies transform once-terminal illnesses into chronic conditions, patients are living longer with increasingly complex needs that require coordination across specialties and care settings. At the same time, social determinants of health further complicate treatment adherence and recovery, challenges that traditional reimbursement models are often not designed to address.

In this environment, philanthropic capital provides the flexibility to test and scale new solutions. Donor funding has accelerated the adoption of artificial intelligence tools from pilot to implementation, improving diagnostic precision and streamlining patient throughput. It has also supported the integration of community health navigators and care coordination roles that reduce preventable readmissions and improve outcomes for patients managing chronic disease.

In many cases, philanthropy enables health systems to pilot innovations that would otherwise be too risky or underfunded within operating budgets.

The Executive Imperative for Health Philanthropy

Embedding Philanthropy in the Organizational Strategic Plan

If philanthropy is expected to become a meaningful and sustainable revenue stream, it must be intentionally embedded within the organization’s strategic plan. When fundraising is positioned as a core financing strategy rather than a supplemental function, it strengthens executive and board-level decision-making, particularly as leaders navigate reimbursement pressures, capital demands, and long-term growth.

Establishing clear annual philanthropic revenue targets, along with three-to-five-year pipeline projections, enables leadership teams to anticipate revenue with greater confidence and strategically allocate resources. This forward-looking approach allows organizations to plan for capital investments, program expansion, and innovation with a diversified funding model in mind.

To fully integrate philanthropy into executive strategy, development metrics must be reflected in the broader strategic plan. Clear KPIs, including pipeline growth, major gift activity, campaign readiness benchmarks, and donor retention, should function as enablers of the organization’s overarching vision. At this stage, leadership teams should be asking foundational questions: Who are the funders with the highest potential return on investment? What relationships need to be built or deepened? What internal capabilities must be strengthened to engage them effectively?

Whether philanthropy is being formalized for the first time or scaled to meet greater ambition, several strategic considerations should guide the conversation:

• What structural or cultural barriers are limiting philanthropic revenue growth?
• Is the organization fully leveraging its existing donor and grateful patient base?
• Does the development team have the staffing, systems, and executive access required to elevate philanthropy into a meaningful income stream?
• Are the appropriate giving pathways in place, including annual giving, major and principal gifts, planned giving, corporate partnerships, and foundation support?

This early strategic assessment clarifies where investment is required and where opportunity exists. Organizations that approach philanthropy with the same rigor applied to clinical growth or operational expansion are better positioned to build durable revenue pathways.

Revenue Pathways to Consider

Campaigns as a Governance Strategy
As philanthropy matures within health systems, campaign readiness should be viewed not only as a fundraising milestone but as a governance priority. According to the Association for Healthcare Philanthropy, 72% of high-performing health systems were in active campaigns in 2025. Campaigns require alignment at the highest levels of leadership. Executive teams and boards must be unified around the organization’s vision, five-to-ten-year growth trajectory, anticipated capital investments, strength of the philanthropic pipeline, and external perception of the institution. Without this alignment, campaign execution is significantly more difficult.

Grateful Patient Fundraising
For many healthcare organizations, grateful patient fundraising represents one of the most significant growth opportunities. If this pathway emerges as a priority, leadership must first assess the organization’s culture of philanthropy, clearly define the donor cultivation journey, and outline engagement practices across clinical and development teams. Successful programs require thoughtful collaboration between clinicians and gift officers, along with the appropriate education, guardrails, and compliance infrastructure.

In addition, organizations should evaluate the integration between CRM systems and electronic medical record systems to identify and qualify potential prospects responsibly. Data strategy increasingly plays a central role in building and sustaining a strong pipeline.

Board Engagement as a Strategic Lever
Board members are among the most credible and influential ambassadors for philanthropy. When engaged intentionally, they lend legitimacy to the case for support and expand access to new networks. Development leaders should work closely with individual board members to define clear engagement pathways, whether through peer introductions, hosting cultivation opportunities, or participating in prospect strategy discussions. When willing and prepared, board members can be valuable partners in prospect identification and qualification.

Before pursuing any of these revenue pathways, organizations must first conduct a clear-eyed assessment of their philanthropic maturity, internal alignment, and market opportunity. Building the necessary infrastructure, including experienced leadership, data systems, board engagement, and a culture that supports fundraising, creates the foundation required to translate ambition into sustainable philanthropic growth.

Healthcare leaders are operating in an era defined by financial constraint, clinical complexity, and rising expectations for access, equity, and innovation. Traditional revenue models alone are no longer sufficient to sustain long-term growth while advancing mission. In this environment, philanthropy cannot remain adjacent to strategy—it must be embedded within it.

When intentionally integrated into governance, financial planning, and organizational vision, philanthropic capital becomes more than a fundraising function. It becomes flexible, risk-tolerant funding that enables health systems to pilot innovation, strengthen care coordination, expand access, and invest in long-term resilience. It allows organizations to move from reactive budgeting to proactive transformation.

For executive teams and boards, the imperative is clear: treat philanthropy with the same rigor applied to clinical expansion, capital investment, and operational performance. Health systems that do so will not only diversify revenue but will also build durable pathways to innovation and mission fulfillment. In a volatile healthcare landscape, philanthropy is no longer supplemental — it is a strategic lever shaping the future of care delivery.

Get in touch to learn more about how Orr Group can help your nonprofit design and manage diverse, adaptive, and sustainable fundraising programs.

Niall Keane is a Director at Orr Group. Niall has extensive experience working with stakeholders across organizations to design philanthropic opportunities and implement engagement strategies that promote positive donor experiences and secure philanthropy.